Mydecine Innovations G's ticker is and the CUSIP is 62849F101. A total of 2 filers reported holding Mydecine Innovations G in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HOLLENCREST CAPITAL MANAGEMENT | 23,300 | $2,000 | 0.00% |
| American Research & Management Co. | 2,000 | $0 | 0.00% |